In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Panel Looks To Upcoming Study To Fill Evidence Gaps For Carotid Artery Disease

This article was originally published in The Pink Sheet Daily

Executive Summary

There's a lot more to learn about which treatment to choose for carotid atherosclerosis patients, Medicare advisors said this week. A new trial in the works that would compare both surgery and stenting to standalone medical therapy presents a good opportunity to fill the gaps.

You may also be interested in...



News In Brief

Abbott’s RX Acculink

New Guidelines Give Near-Equal Measure To Carotid Stenting And Surgery

Carotid stenting is a viable alternative to surgery for patients at risk for stroke due to clogged neck arteries, according to new guidelines issued Jan. 31 by 14 neuroscience, cardiology and surgical specialty societies.

Blues' TEC Delivers Negative Assessment On Carotid Stenting

A recent negative BlueCross BlueShield Association technology assessment could be another barrier to expanded coverage of carotid stenting

Related Content

Topics

UsernamePublicRestriction

Register

PS073319

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel